Insufficient adaptation of hypoglycaemic threshold for cognitive impairment in tightly controlled type 1 diabetes

Diabetes and Metabolism

Volumn 26, Issue 1, 2000, Pages 58-64

  Taverna, M J ^a   M'Bemba, J ^a   Sola, A ^a   Chevalier, A ^a   Slama, G ^a   Selam, J L ^a  

^a HÔTEL DIEU   (France)

Author keywords

4 choice reaction time; Cognitive function; Counterregulation; Diabetes; Hypoglycaemia

Indexed keywords

INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT SELECTION;

ADULT; AWARENESS; BLOOD GLUCOSE; COGNITION; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FEMALE; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NOREPINEPHRINE;

EID: 0034114120     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term-complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
2. Wan PH, Lau J, Chalmore TC. Meta-analysis of effects of intensive blood glucose control on the development of the microvascular complications of type 1 diabetes, Lancet, 1993, 341, 1306-1309.
3. American Diabetes Association. Position statement: implication of the Diabetes Control and Complications Trial. Clin Diabetes, 1993, 11, 91-96.
4. The Diabetes Control and Complication Trial Research Group. Epidemiology of severe hypoglycaemic in the Diabetes Control and Complication Trial. Am J Med. 1991, 90, 450-459.
5. Reichard P, Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes, 1994, 43, 313-317.
6. Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Intensive insulin therapy reduces the counterregulatory hormone responses to hypoglycaemia in patients with type I diabetes. Ann Intern Med. 1985, 103, 184-190.
7. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy reduces the counterregulatory hormone release. Diabetes, 1990, 37, 901-907.
8. Selam JL, Woertz L, Eichner H, Charles MA. Blood glucose levels stimulating hypoglycaemic counterregulation are related to chronic diabetes control. Diabetes Research, 1990, 13, 117-120.
9. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus. N Engl J Med. 1987, 316, 1376-1383.
10. Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, et al. Effects of glycaemic control on protective responses against hypoglycaemia in type 2 diabetes. Diabetes Care, 1998, 21, 283-290.
11. Davis MR, Shamoon H. Deficient counterregulatory hormone responses during hypoglycaemia in a patient with insulinoma. J Clin Endocrinol Metab, 1991, 72, 788-792.
12. Cryer PE. Hypoglycaemia begets hypoglycaemia in IDDM. Diabetes, 1993, 42, 1691-1693.
13. Ovalle F, Fanelli CG, Paramore DS, Hershey T, Craft S, Cryer PE. Brief twice-weekly episodes of hypoglycaemia reduce detection of clinical hypoglycaemia in type I diabetes mellitus. Diabetes, 1998, 47, 1472-1479.
14. Bolli GB. Hypoglycaemia unawareness. Diabetes Metab, 1997, 23, 29-35.
15. Amiel SA. R.D. Lawrence Lecture 1994. Limits of normality: the mechanisms of hypoglycaemia unawareness. Diabet Med, 1994, 11, 918-924.
16. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, et al. Reduced awareness of hypoglycaemia in adults with IDDM. Diabetes Care, 1995, 18, 517-522.
17. Borg WP, Borg MA, Tamborlane WV. The brain and hypoglycaemic counterregulation: insights from hypoglycaemic clamp studies. Diabetes Spectrum, 1997, 10, 33-38.
18. Baker D, Evans M, Cryer P, Sherwin R. Hypoglycaemia and glucose sensing. Diabetologia, 1997, 40, B83-88.
19. Selam JL. Cognitive risk of repeated hypoglycaemias in diabetic patient. Diabetes Metab, 1998, 24, 167-172.
20. Frier BM, Deary IJ. Effets immédiats et à long terme de l'hypoglycémie sur les fonctions cognitives. Journées de Diabétologie de l' Hôtel-Dieu de Paris 1994, Ed. Flammarion Médecine-Sciences 251-264.
21. Amiel SA. Cognitive function testing in studies of acute hypoglycaemia: rights and wrongs. Diabetologia, 1998, 41, 713-719.
22. Heller SR, Macdonald IA. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med, 1996, 13, 607-61.
23. Fanelli CG, Pampanelli S, Porcellati F, Bolli GB. Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. Diabetologia, 1998, 41, 720-723.
24. Boyle PJ, Nagy RJ, O'Connor, Kempers SF, et al. Adaptation in brain glucose uptake following recurrent hypoglycaemia. Proc Natl Acad Sci USA, 1994, 91, 9352-9356.
25. Fanelli CG, Paramore D, Hershey T, Terkamp C, et al. Impact of nocturnal hypoglycaemia on hypoglycaemic cognitive dysfunction the following morning in IDDM. Diabetes, 1996, [Suppl I] 55A, 198 (Abstract).
26. Jones TW, Borg WP, Borg MA, Tamborlane WV, Sherwin RS, et al. Resistance to neuroglycopenia: an adaptative response during intensive insulin treatment of diabetes. J Clin Endocrinol Metab. 1997, 82, 1713-1718.
27. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia, 1995, 38, 1412-1418.
28. Amiel SA, Pottinger RC, Archibald HR, Gale EAM, et al. Effect of antecedent glucose control on cerebral function during hypoelycaemia. Diabetes Care, 1991, 14, 109-118.
29. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycaemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest, 1993, 91, 819-828.
30. Widom B, Simonson DC. Glycaemic control and neuropsychologic function during hypoglycaemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med, 1990, 112, 904-912.
31. Rudkowski R, Antony G. The effect of immediate polyethylene glycol precipitation on free insulin measurements in diabetic patients with insulin antibodies. Diabetes, 1986, 35, 253-257.
32. Aguilar-Parada E, Eisentraut AM, Linger RH. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci, 1969, 257, 415-419.
33. Passon PG, Peuler JD. A simplified radiometric assay for plasma norepinephrine and epinephrine. Ann Biochem, 1973, 51, 618-631.
34. Hepburn DA, Deary IJ, Frier BM, Patrick AW, Quinn JD, Fisher BM. Symptoms of acute insulin-induced hypoglycaemia in humans with and without IDDM. Factor-Analysis approach. Diabetes Care, 1991, 14, 949-57.
35. Wilkinson RT, Houghton D. Portable four-choice reaction time test with magnetic tape memory. Behav Res Meth Instrumentation, 1975, 7, 441-446.
36. Kerr D, Macdonald IA, Tattersall RB. Patients with type 1 diabetes adapt acutely to sustained mild hypoglycaemia. Diabet Med, 1991, 8, 123-128.
37. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycaemic thresholds for counterregulatory hormone release. Diabetes, 1988, 37, 901-907.
38. Clutter WE, Bier DM, Shah SD, Cryer PE. Epinephrine plasma metabolic clearence rates and physiologic thresholds for metabolic and hemodinamic actions in man. J Clin Invest, 1980, 66, 94-101.
39. Strachan MWJ, Frier BM, Deary IJ. Cognitive assessment in diabetes: the need for consensus. Diabet Med. 1997, 14, 421-422.
40. Holmes CS, Hayford JT, Gonzalez JL, Weydert JA. A survey of different functioning at different glucose levels in diabetic persons. Diabetes Care, 1983, 6, 180-185.
41. Holmes CS, Koepke KM, Thompson RG, Gyves PW, et al. Verbal fluency and naming performance in type 1 diabetes at different blood glucose concentrations. Diabetes Care, 1987, 7, 454-459.
42. Heller SR, Macdonald IA, Herbert M, Tattersall RB. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet, 1987, ii, 359-363.
43. Matyka K, Evans M, Lomas J, Cranston I, et al. Altered hierachy of protective responses against severe hypoglycaemia in normal aging in healthy men. Diabetes Care, 1997, 20, 135-141.
44. Cranston I, Lomas J, Maran A, Macdonald I, et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet, 1994, 344, 283-287.
45. Evans ML, Lomas J, Pernet A, Hopkins D, Joseph S, Amiel SA. Cognitive dysfunction coincides with the onset of hypoglycaemia and only improves after glucose recovery. 32th Annual Meeting of the EASD. Satellite Symposium August 30-31, 1996, Bled, Slovenia 24 (Abstract).
46. Kerr D, Macdonald IA, Tatersall RB. Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counterregulatory hormones. Diabetologia, 1989, 32, 249-254.
47. Gold AE, Deary IJ, MacLeod KM, Thomson KJ, Frier BM. Cognitive function during insulin-induced hypoglycaemia in humans: short-term cerebral adaptation does not occur. Psychopharmacology, 1995, 119, 325-333.